Search results (25)
« Back to NewsUnder-40s diagnosed with type 2 diabetes have a mortality rate four times higher than the general population
24 October 2024
People diagnosed with type 2 diabetes before 40 years of age, have nearly four times the risk of death compared with the general UK population, a new study carried out at the University of Oxford’s Radcliffe Department of Medicine has found.
Hydroxychloroquine provides moderate COVID-19 prevention
16 September 2024
COPCOV, the world’s largest COVID-19 chemoprevention study, published results today showing that hydroxychloroquine (HCQ) has a moderate benefit in preventing COVID-19. The COPCOV trial was led globally by the Mahidol Oxford Tropical Medicine Research Unit (MORU), Thailand. The Diabetes Trials Unit (DTU) was the UK coordinating centre for the trial, helped develop the protocol, and was responsible for managing UK sites, approvals and procedures.
Patients receiving steroids are more than twice as likely to develop diabetes, UK study has found
10 September 2024
Patients who are being treated with systemic glucocorticoids are more than twice as likely to develop diabetes as those not receiving the treatment, a new study by researchers at the Radcliffe Department of Medicine’s Diabetes Trial Unit has found.
Early blood glucose control for people with type 2 diabetes is crucial for reducing complications and prolonging life
18 May 2024
Research led by scientists from the Universities of Oxford and Edinburgh has found that early good blood glucose control can minimise the lifetime risk of diabetes-related complications, including heart attacks, kidney failure and vision loss.
The LEGEND-D Trial – which aims to prevent low blood sugar levels in type 1 diabetes – is open to recruitment
16 April 2024
The first participant has completed initial study activities and is now randomised to one of the trial’s arms.
DTU to run clinical trial for Dementias Platform UK in nationwide bid to revolutionise dementia diagnosis using blood tests
4 April 2024
Dementias Platform UK has been awarded over £4 million to carry out countrywide trials to identify accurate and quick blood tests that can diagnose dementia, in a bid to improve management and patient and carer wellbeing. RDM's Diabetes Trials Unit will run the clinical trial component of the challenge.
UK’s first registry to be set up for those at risk of type 1 diabetes
11 March 2024
Researchers from the Oxford BRC and other collaborating organisations have received funding to set up a UK registry for children and adults who are at risk of type 1 diabetes and have tested positive for diabetes autoantibodies.
Professor Rury Holman wins 2024 Banting Medal for Scientific Achievement
6 March 2024
The American Diabetes Association (ADA) has announced this year's National Scientific and Health Care Achievement Award recipients.
Trial of ‘artificial pancreas’ for people with cystic fibrosis-related diabetes is off to a strong start
6 March 2024
The first group of participants recruited into the CL4P-CF trial is helping to test the effect of using an automated insulin delivery system in people with cystic fibrosis-related diabetes.
Live to eat and eat to live longer
5 December 2023
New research shows that following the Eatwell Guide recommendations or longevity-associated dietary patterns is likely to improve life expectancy in people with unhealthy or typical dietary patterns in the UK.
How to be a good Chief Investigator: one-day UKCRC CTU Network-supported workshops
5 December 2023
Do you know a Chief Investigator who would like a refresher on how to interact with a clinical trials unit (CTU)? Or one who is about to work with you and wants to get up to speed? Or perhaps someone initially considering working with a CTU?
Trial to test diabetes drug for reducing risk for Alzheimer's Disease
22 September 2022